Percutaneous transluminal coronary angioplasty: therapeutic intervention in the cardiac catheterization laboratory.
Although PTCA is applicable to a relatively small percentage of the population today, its potential of major significance in the treatment of coronary atherosclerosis is appreciable. As the procedure is extended to multivessel disease, increasing numbers of patients may benefit from this nonsurgical intervention. Increasing experience and expertise in the performance of the procedure will contribute to a decreasing incidence of complications and will substantiate PTCA as a reasonable alternative to surgical intervention and an acceptable therapeutic modality in selected patients.